Next milestone: Gerresheimer Boleslawiec in Poland
Düsseldorf/Barcelona, October 4, 2016 - Gerresheimer has set up an investment program spanning several years to install state-of-the-art converting machines for vial manufacturing at all its plants. The latest-generation machines and global high standards will enable it to meet even more stringent future requirements of product quality. The first two machines have now been installed and put into operation in Boleslawiec, location of one of Gerresheimer’s two Technical Competence Centers for vial production in Europe. The third machine is scheduled for installation soon, followed by additional new machines in 2017 and 2018.
“Our investments have already paid off; reflected by the fact that the new machines manufacture vials in cosmetic and dimensional quality that by far surpasses the industry standard. That’s why the first customer feedback has been so positive,” said Jens Heymann, Global Vice President Finance & Controlling und Senior Vice President Europe & Asia Tubular Glass.
The aim of this project has been absolutely clear from day one: Gerresheimer wants to supply its customers with significantly improved vials in the highest possible quality. Gerresheimer Boleslawiec is the European milestone confirming that the global project is fully on schedule.
Extensive renovation work was necessary before the new machines could be installed. The floor and lighting systems were replaced, the clean room was upgraded and extended, and the existing machine layout was changed. These are just a few aspects of the extensive refurbishment program that was implemented to prepare the plant for the ultra-modern machines.
Vials are one of Gerresheimer’s top-selling products. They are also one of the most frequently used pharmaceutical packaging products in the world. Gerresheimer manufactures them in the USA, Asia and Europe with filling volumes of between 1 and 50 ml.
Gerresheimer is a leading global partner to the pharma and healthcare industries. The company’s special glass and plastic products contribute to health and well-being. Gerresheimer is a global organization with 11,000 employees and manufacturing operations in the local markets, close to customers. It has over 40 production facilities in Europe, North and South America and Asia generating revenue in excess of EUR 1.4 billion. The comprehensive product portfolio includes pharmaceutical packaging products as well as convenient and safe drug delivery systems such as insulin pens, inhalers, pre-fillable syringes, vials, ampoules, bottles and containers for liquid and solid pharmaceuticals with closure and safety systems, plus cosmetic packaging products.